Search results for "Risk score"

showing 10 items of 168 documents

A Multi-Locus Genetic Risk Score for Primary Open-Angle Glaucoma (POAG) Variants Is Associated with POAG Risk in a Mediterranean Population: Inverse …

2017

Primary open-angle glaucoma (POAG) is a leading cause of blindness worldwide. The genetics of POAG are complex, and population-specific effects have been reported. Although many polymorphisms associated with POAG risk have been reported, few studies have analyzed their additive effects. We investigated, in a southern European Mediterranean population, the association between relevant POAG polymorphisms, identified by initial genome-wide association studies (GWASs) and POAG risk, both separately and as an aggregated multi-locus genetic risk score (GRS). Also, bearing in mind that oxidative stress is a factor increasingly recognized in the pathogenesis of POAG, we analyzed the potential assoc…

Male0301 basic medicineOncologyprimary open-angle glaucomagenetic structuresmedicine.medical_treatmentvitamin CGenome-wide association studyAscorbic Acidvitamin EBioinformaticslcsh:Chemistry0302 clinical medicineRisk FactorsGenotypeVitamin EGWASgeneticsVitamin Clcsh:QH301-705.5Spectroscopyeducation.field_of_studyMediterranean RegionGeneral MedicineMiddle AgedGenetic risk scoreComputer Science ApplicationsnutritionFemalePrimary open-angle glaucomaGlaucoma Open-Anglemedicine.medical_specialtyGenotypePopulationgenetic risk scoreArticleCatalysisInorganic Chemistry03 medical and health sciencesInternal medicineGeneticsmedicineHumansGenetic Predisposition to DiseasePhysical and Theoretical ChemistryeducationMolecular BiologyNutritionAgedGenetic associationPolymorphism Geneticbusiness.industryVitamin EfungiOrganic Chemistryprimary open-angle glaucoma; genetics; GWAS; nutrition; vitamin C; vitamin E; genetic risk scoreCase-control studyAscorbic acideye diseasesConfidence interval030104 developmental biologylcsh:Biology (General)lcsh:QD1-999Genetic LociCase-Control Studies030221 ophthalmology & optometrybusinessGenome-Wide Association StudyInternational Journal of Molecular Sciences
researchProduct

Increases in Plasma Tryptophan Are Inversely Associated with Incident Cardiovascular Disease in the Prevención con Dieta Mediterránea (PREDIMED) Stud…

2017

Background: During development of cardiovascular disease (CVD), interferon-γ-mediated inflammation accelerates degradation of tryptophan into downstream metabolites. A Mediterranean diet (MedDiet) consisting of a high intake of extra-virgin olive oil (EVOO), nuts, fruits, vegetables, and cereals has been demonstrated to lower the risk of CVD. The longitudinal relation between tryptophan and its downstream metabolites and CVD in the context of a MedDiet is unstudied.Objective: We sought to investigate the relation between metabolites in the tryptophan-kynurenine pathway and CVD in the context of a MedDiet pattern.Methods: We used a case-cohort design nested in the Prevención con Dieta Medite…

Male0301 basic medicinemedicine.medical_specialtyMediterranean dietEpidemiologyMetaboliteSistema cardiovascular -- MalaltiesMedicine (miscellaneous)Context (language use)030204 cardiovascular system & hematologyDiet MediterraneanLower riskDIETA MEDITERRÀNIACohort Studies03 medical and health scienceschemistry.chemical_compound0302 clinical medicineKynurenic acidMediterranean dietInternal medicinemedicineHumansMetabolomicsGenomics Proteomics and MetabolomicsDieta -- Mediterrània Regió de laAgedNutritionCiències de la salutNutrition and DieteticsFramingham Risk ScoreErratabusiness.industryMALALTIES CARDIOVASCULARSTryptophanCase-control studyHealth sciencesfood and beveragesMiddle AgedCardiovascular diseaseCiencias de la salud030104 developmental biologyEndocrinologychemistryCardiovascular DiseasesCase-Control StudiesFemalebusiness0022-3166Kynurenine
researchProduct

Twelve Variants Polygenic Score for Low-Density Lipoprotein Cholesterol Distribution in a Large Cohort of Patients With Clinically Diagnosed Familial…

2022

: Background A significant proportion of individuals clinically diagnosed with familial hypercholesterolemia (FH), but without any disease-causing mutation, are likely to have polygenic hypercholesterolemia. We evaluated the distribution of a polygenic risk score, consisting of 12 low-density lipoprotein cholesterol (LDL-C)-raising variants (polygenic LDL-C risk score), in subjects with a clinical diagnosis of FH. Methods and Results Within the Lipid Transport Disorders Italian Genetic Network (LIPIGEN) study, 875 patients who were FH-mutation positive (women, 54.75%; mean age, 42.47±15.00 years) and 644 patients who were FH-mutation negative (women, 54.21%; mean age, 49.73±13.54 years) wer…

MaleAdultMultifactorial InheritanceSettore MED/09 - Medicina Internafamilial hypercholesterolemia; molecular diagnosis; polygenic risk score; Adult; Cholesterol LDL; Female; Humans; Middle Aged; Multifactorial Inheritance; Mutation; Gene Regulatory Networks; Hyperlipoproteinemia Type IIfamilial hypercholesterolemiaCholesterol LDLMiddle AgedLDLHyperlipoproteinemia Type IICholesterolmolecular diagnosispolygenic risk scoreMutationHumansFemaleGene Regulatory Networksmolecular diagnosifamilial hypercholesterolemia; molecular diagnosis; polygenic risk score
researchProduct

Incidence and risk factors of post-engraftment invasive fungal disease in adult allogeneic hematopoietic stem cell transplant recipients receiving or…

2015

Studies that analyze the epidemiology and risk factors for invasive fungal disease (IFD) after engraftment in alloSCT are few in number. This single-center retrospective study included 404 alloSCT adult recipients surviving > 40 days who engrafted and were discharged without prior IFD. All patients who received >= 20 mg/day of prednisone were assigned to primary oral prophylaxis (itraconazole or low-dose voriconazole). The primary end point was the cumulative incidence (CI) of probable/proven IFD using the European Organization for Research and Treatment of Cancer and Mycoses Study Group (EORTC/MSG) criteria. The independent prognostic factors after multivariate analyses were used to constr…

MaleAntifungal AgentsTransplantation ConditioningPremedicationmedicine.medical_treatmentMULTICENTERAdministration OralHematopoietic stem cell transplantationEchinocandinsCOMPETING RISKCaspofunginRisk FactorsCause of DeathINFECTIONGranulocyte Colony-Stimulating FactorEPIDEMIOLOGYCumulative incidenceTreatment FailureFramingham Risk ScoreIncidenceIncidence (epidemiology)Hematopoietic Stem Cell TransplantationHematologyMiddle AgedAllograftsHematologic NeoplasmsVORICONAZOLEDrug Therapy CombinationFemaleASPERGILLOSISRisk assessmentFungemiamedicine.drugAdultmedicine.medical_specialtyNeutropeniaANTIFUNGAL PROPHYLAXISNeutropeniaRisk AssessmentITRACONAZOLEMedication AdherenceImmunocompromised HostLipopeptidesYoung AdultAmphotericin BInternal medicinemedicineAspergillosisHumansAgedRetrospective StudiesVoriconazoleTransplantationbusiness.industryRetrospective cohort studyFLUCONAZOLETriazolesmedicine.diseaseSurvival AnalysisSurgeryMycosesPatient CompliancebusinessSCT
researchProduct

Short-Term Effects of a Combined Nutraceutical on Lipid Level, Fatty Liver Biomarkers, Hemodynamic Parameters, and Estimated Cardiovascular Disease R…

2017

Introduction: There is a growing interest in nutraceuticals improving cardiovascular risk factor levels and related organ damage. Methods: This double-blind, placebo-controlled randomized clinical trial aims to compare the effect of a combined nutraceutical containing red yeast rice (10 mg), phytosterols (800 mg), and l-tyrosol (5 mg) on lipid profile, blood pressure, endothelial function, and arterial stiffness in a group of 60 patients with polygenic hypercholesterolemia resistant to Mediterranean diet. Results: After 8 weeks of treatment, when compared to the placebo group, the active treated patients experienced a more favorable percentage change in total cholesterol (−16.3% vs 9.9…

MaleBlood Pressure030204 cardiovascular system & hematologyGastroenterologychemistry.chemical_compoundDietary supplement0302 clinical medicineRisk FactorsPhytosterolPharmacology (medical)030212 general & internal medicineEndothelial dysfunctionOriginal ResearchFramingham Risk Scoremedicine.diagnostic_testAnticholesteremic AgentsFatty liverPhytosterolsGeneral MedicineMiddle AgedDietary supplementsCholesterolBiochemistryCardiovascular DiseasesFemaleNutraceuticalsNutraceuticalAdultmedicine.medical_specialtyl-TyrosolHypercholesterolemiaPlacebo03 medical and health sciencesDouble-Blind MethodInternal medicinemedicineHumansRisk factorBiological ProductsCholesterolbusiness.industryHemodynamicsmedicine.diseaseCardiovascular disease riskBlood pressurechemistryRed yeast riceArterial stiffnessLipid profilebusinessBiomarkers
researchProduct

Cost-effectiveness of optimized adherence to prevention guidelines in European patients with coronary heart disease : results from the EUROASPIRE IV …

2018

Background: This study aims to assess the cost-effectiveness of optimized guideline adherence in patients with a history of coronary heart disease. Methods: An individual-based decision tree model was developed using the SMART risk score tool which estimates the 10-year risk for recurrent vascular events in patients with manifest cardiovascular disease (CVD). Analyses were based on the EUROASPIRE IV survey. Outcomes were expressed as an incremental cost-effectiveness ratio (ICER). Results: Data from 4663 patients from 13 European countries were included in the analyses. The mean estimated 10-year risk for a recurrent vascular event decreased from 20.13% to 18.61% after optimized guideline a…

MaleCardiac & Cardiovascular SystemsCost effectivenessmedicine.medical_treatmentCost-Benefit AnalysisCoronary DiseaseDisease030204 cardiovascular system & hematology0302 clinical medicineOlder patientsMedicine030212 general & internal medicineguidelinesEUROASPIRE1102 Cardiorespiratory Medicine and Haematologyhealth care economics and organizationsBIOMEDICINA I ZDRAVSTVO. Kliničke medicinske znanosti. Interna medicina.Framingham Risk ScoreSecondary preventionASSOCIATIONMiddle AgedhumanitiesCoronary heart diseaseEuropeDENSITY-LIPOPROTEIN CHOLESTEROLPractice Guidelines as TopicTRIALFemaleGuideline AdherenceCardiology and Cardiovascular MedicineLife Sciences & Biomedicinesecondary prevention ; guidelines ; cost-effectiveness ; coronary heart disease ; EUROASPIREsecondary preventionmedicine.drugINTERVENTIONSmedicine.medical_specialtyEZETIMIBEGuidelinesEVENTS03 medical and health sciencesEzetimibeInternal medicineHumansIn patientcoronary heart diseaseBIOMEDICINE AND HEALTHCARE. Clinical Medical Sciences. Internal Medicine.cost-effectivenessMETAANALYSISAgedScience & Technologybusiness.industryDecision TreesSMOKING-CESSATIONCoronary heart diseaseTHRESHOLDSCardiovascular System & HematologyCardiovascular System & CardiologySmoking cessationCost-effectivenessbusinessSTATIN TREATMENT
researchProduct

Schizophrenia polygenic risk score and long-term success in the labour market: A cohort study

2022

Publisher Copyright: © 2022 The Authors Employment is rare among people with a schizophrenia diagnosis. Meanwhile, a genetic liability for schizophrenia may hinder labour market performance. We studied how the polygenic risk score (PGS) for schizophrenia related to education and labour market outcomes. We found that a higher PGS was linked to lower educational levels and weaker labour market outcomes as well as a higher likelihood of receiving social income transfers, particularly among men. Assuming that the link is causal, our results indicate that individuals with schizophrenia or schizophrenia-related traits have a weakened ability to fully participate in the labour market, potentially …

MaleEmploymentperinnölliset tauditskitsofrenia515 Psychologytyöllistyminen3121 Internal medicinebehavioral disciplines and activities3124 Neurology and psychiatryperinnöllinen alttiusEducationCohort Studiestyömarkkina-asemaPsychiatry and Mental healthkoulutustasoPolygenic risk scoreRisk FactorsEarningsSocial income transfersmental disordersSchizophreniaEducational StatusHumansBiological PsychiatryJournal of Psychiatric Research
researchProduct

Pasireotide treatment reduces cardiometabolic risk in Cushing’s disease patients: an Italian, multicenter study

2018

Purpose: Patients with Cushing’s disease (CD) experience metabolic alterations leading to increased cardiovascular mortality. Recently, the visceral adiposity index (VAI) has been proposed as a marker of visceral adipose tissue dysfunction (ATD) and of the related cardiometabolic risk. We aimed to evaluate the impact of 12-month pasireotide treatment on cardiometabolic risk in CD patients. Methods: This is a multicentre, prospective, and observational study. Sixteen CD patients, referred to the Endocrine Units of the University Hospitals of Messina, Napoli, Padova, and Palermo (Italy), successfully treated with pasireotide for 12 month have been enrolled. In all patients, we assessed anthro…

MaleEndocrinology Diabetes and MetabolismCardiometabolic risk Cushing’s disease hypercortisolism pasireotide visceral adiposity indexLongitudinal StudieDisease030204 cardiovascular system & hematologySettore MED/13 - Endocrinologiachemistry.chemical_compound0302 clinical medicineEndocrinologyRisk FactorsMedicineLongitudinal StudiesProspective StudiesAdiposityFramingham Risk ScoreCushing’s diseaseCushing’s diseaseMiddle AgedPasireotideDiabetes and MetabolismHeart DiseaseItalyAtherosclerosiObesity AbdominalFemaleSomatostatinHumanAdultmedicine.medical_specialtyWaistHeart DiseasesHypercortisolism030209 endocrinology & metabolismIntra-Abdominal Fat03 medical and health sciencesMetabolic DiseasesInternal medicineDiabetes mellitusCardiometabolic risk; Cushing’s disease; Hypercortisolism; Pasireotide; Visceral adiposity index; Endocrinology Diabetes and Metabolism; EndocrinologyHumansPituitary ACTH Hypersecretionbusiness.industryRisk FactorCushing's diseaseAnthropometryAtherosclerosismedicine.diseasePasireotideCardiometabolic riskMetabolic DiseaseVisceral adiposity indexProspective StudiechemistryObservational studybusiness
researchProduct

Polygenic Score for Physical Activity Is Associated with Multiple Common Diseases

2021

Supplemental digital content is available in the text.

MaleEpidemiologyPhysical fitnessType 2 diabetesDiseaseLogistic regressionTYPE 2 DIABETESOrthopedics and Sports Medicine315 Sport and fitness sciencesPREDICTORSChildkohorttitutkimusFinlandAged 80 and oversairastavuusHERITABILITYGenetic PleiotropyriskitekijätMiddle AgedCardiovascular DiseasesChild PreschoolCohortComputingMethodologies_DOCUMENTANDTEXTPROCESSINGFemaleSMOKINGgeneettiset tekijätfyysinen aktiivisuusAdultGenetic Markerskuolleisuusmedicine.medical_specialtyAdolescentGenotypePhysical Therapy Sports Therapy and RehabilitationEXERCISEpitkittäistutkimusLower riskRisk AssessmentYoung AdultMetabolic DiseasesInternal medicineClinical Decision RulesBENEFITSmedicineHumansAgedbusiness.industryRISK SCORESCardiometabolic Risk FactorsInfantOdds ratiomedicine.diseaseGENEBODY-MASS INDEXLogistic ModelsCase-Control StudiesLinear Modelssydän- ja verisuonitauditbusinessBody mass indexGenome-Wide Association Study
researchProduct

Genetic endowments, parental resources and adult health: Evidence from the Young Finns Study

2017

This paper uses longitudinal survey data linked to administrative registers to examine socioeconomic gradients in health, particularly whether the effects of genetic endowments interact with the socioeconomic resources of the parental household. We find that genetic risk scores contribute to adult health measured by biomarkers. This result is consistent with the findings from genome-wide association studies. Socioeconomic gradients in health differ based on biomarker and resource measures. Family education is negatively related to obesity and the waist-hip ratio, and family income is negatively related to low-density lipoprotein cholesterol and triglyceride levels. Parental resources do not…

MaleGerontologyHealth (social science)Social Determinants of HealthHealth StatusbiomarkkeritGenome-wide association studyBody Mass Index0302 clinical medicineSurveys and QuestionnairesLongitudinal Studies030212 general & internal medicine050207 economicsFinlandgenetic risk scores05 social sciencesta3142riskitekijätIncomeFemaleSportsAdultparental resourcesgenetiikkaResource (biology)Kansanterveystiede ympäristö ja työterveys - Public health care science environmental and occupational healthympäristötekijätFamily income03 medical and health sciencesHistory and Philosophy of Science0502 economics and businessFood QualitymedicineHumansSocioeconomic statussosioekonomiset tekijätTriglyceridesAdult healthGenetic associationta511business.industryta1184Cholesterol HDLadult healthbiomarkersCholesterol LDLmedicine.diseaseObesityperhetaustaSocioeconomic Factorsmarkkeritgenome-wide association studiesSurvey data collectionterveyserotbusinessGenome-Wide Association StudyDemographySocial Science & Medicine
researchProduct